Literature DB >> 10396290

Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis.

G Mitterbauer1, K Winkler, H Gisslinger, K Geissler, K Lechner, C Mannhalter.   

Abstract

Chronic myeloproliferative diseases (MPDs) are not associated with consistent cytogenetic or molecular abnormalities. Demonstration of clonal cell growth by analysis of X-chromosome inactivation (XCI) patterns in females provides a promising tool for diagnosis. However, this technique can be complicated by excessive lyonization of normal cells mimicking clonal cell growth: We analyzed XCI patterns at the human androgen receptor (HUMARA) locus in 146 healthy females, 65 women with secondary neutrophilia, 31 women with reactive thrombocytosis, and 86 women with chronic MPDs. A skewed XCI pattern with greater than 75% amplification of 1 allele (allele ratio > 3:1) was found in 22 (9.1%) of 242 control subjects. The incidence of skewing was statistically significantly lower in women younger than 30 years (2/73) compared with women older than 60 years (10/53). Of 86 patients with a chronic MPD, 71 (82%) exhibited an allele ratio greater than 3:1, whereas only 10 (12%) of 86 age-matched control subjects showed a skewed XCI pattern. Although statistical evaluation of the data showed a significant difference between patients with a chronic MPD and control subjects, proof of clonality in individual, especially elderly, patients is difficult.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10396290     DOI: 10.1093/ajcp/112.1.93

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis.

Authors:  Ross L Levine; Claude Belisle; Martha Wadleigh; David Zahrieh; Stephanie Lee; Pierre Chagnon; D Gary Gilliland; Lambert Busque
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

2.  Elastofibroma: clonal fibrous proliferation with predominant CD34-positive cells.

Authors:  Masanori Hisaoka; Hiroshi Hashimoto
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

Review 3.  The pathogenesis of chronic myeloproliferative diseases.

Authors:  A Tefferi
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

4.  Evidence of clonality in chronic neutrophilic leukaemia.

Authors:  J Böhm; S Kock; H E Schaefer; P Fisch
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

5.  Clonal analysis of granulocyte-monocyte colony-forming unit cells with the human androgen receptor gene in chronic myeloid leukemia.

Authors:  Salem Akel; Despina Mavroyanni; Xenophon Yataganas; Evagelos Terpos; John Meletis; Kostas Anargyrou; Niki Stavrogianni; Gerasimos-Alexander Pangalis; Dimitris Loukopoulos; Nora Viniou
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

6.  The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferations.

Authors:  Michaël Boudewijns; Jacques J M van Dongen; Anton W Langerak
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

7.  TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML.

Authors:  Peter Valent; Susanne Herndlhofer; Mathias Schneeweiß; Bernd Boidol; Anna Ringler; Stefan Kubicek; Karoline V Gleixner; Gregor Hoermann; Emir Hadzijusufovic; Leonhard Müllauer; Wolfgang R Sperr; Giulio Superti-Furga; Christine Mannhalter
Journal:  Oncotarget       Date:  2017-04-04

8.  Cross-species examination of X-chromosome inactivation highlights domains of escape from silencing.

Authors:  Bradley P Balaton; Oriol Fornes; Wyeth W Wasserman; Carolyn J Brown
Journal:  Epigenetics Chromatin       Date:  2021-02-17       Impact factor: 4.954

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.